Skip to content

Verification of Homoeopathic medicines for the treatment of Allergic Rhinitis.

Efficacy of Individualized Homoeopathic medicines in Persistent and Perennial Allergic Rhinitis: Double Blind, Randomized, Placebo-Controlled Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096811
Enrollment
140
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J308- Other allergic rhinitis

Interventions

Intervention1: Individualized Homoeopathic Medicine: Experimental arm will receive individualized homoeopathic medicine after detailed case taking and repertorization. Individualized homoeopathic medi

Sponsors

Dr Reshma Chandrabhanji Hiwrale
Lead Sponsor
Dr Om Prakash Singh
Collaborator
Dr Tulika
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from Allergic Rhinitis persistent and perennial variety and of moderate intensity for more than 1 year. 2. Atopic: reactive to inhaled allergens 3. Literate patients: can read hindi or/and english 4. Providing written informed consent to participate in the trial.

Exclusion criteria

Exclusion criteria: 1.Nasal abnormalities causing obstruction, e.g. nasal polyp and deviated nasal septum. 2.Allergen avoidance in the past 6 weeks. 3.Away from usual environment for more than 1 week during the trial. 4.Respiratory infections. 5.Patients at risk of developing bronchial asthma. 6.Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life. 7.Patients who are too sick for consultation. 8.Unwilling to take part and not giving consent to join the study. 9.Unable to read the patient information sheet. 10.Pregnant, puerperal women, and lactating mothers. 11.Substance abuse and/or dependence. 12.Self-reported immunocompromised state. 13.Use of oral or parenteral steroids in the past 6 months. 14.Conventional desensitization in the past 6 months. 15.Previous homeopathic immunotherapy for perennial allergic rhinitis. 16.Undergoing homeopathic treatment for any chronic disease within the last 6 months.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of individualized homoeopathic medicine in comparison with placebo in treatment of persistent and perennial allergic rhinitis.Timepoint: 3 months

Secondary

MeasureTime frame
1. to detect the group differences in RQLQ and VAS measures of nasal, non-nasal and and global severity and QOL over 3 months. 2. To shortlist the most frequently indicated homoeopathic medicines in the treatment of allergic rhinitis.Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Om Prakash Singh

State National Homoeopathic medical College and hospital Gomtinagar lucknow

vijay04pushkar@gmail.com9415466529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026